ITGAM and exocrine pancreatic carcinoma: Additionally, gemcitabine has been shown to enhance vaccine efficacy by obviating CD11b+/Gr-1+ myeloid-derived suppressor cells (MDSCs) in a murine model of pancreatic carcinoma [42], and vice versa [43].